Vālenz Health
Vālenz Health Appoints Vince Cole Chief Executive Officer
Vālenz Health announced a leadership change on June 1, 2026. Vālenz Health appointed Ontellus’s former CEO Vince Cole as Chief Executive Officer, succeeding Rob Gelb, to position the company for its next phase of growth and expansion.
What changed
Vince Cole was named Chief Executive Officer. Rob Gelb, who spent seven and a half years at the company, will transition to the role of Non-Executive Chairman of the Board of Directors.
- Leader: Vince Cole
- Role: Chief Executive Officer
- Effective: Not specified in the announcement
- Announcement date: June 1, 2026
Leadership background
Cole has more than three decades of executive leadership experience and most recently served as Chief Executive Officer of Ontellus. He previously was CEO, Americas, of Charles Taylor and of Crawford and Company, and held executive positions at Activa Medical, Aggio Medical, Genworth Financial, and General Electric.
The mandate
Vālenz Health said Cole’s appointment follows a succession process aimed at positioning the company for its next phase of growth and expansion. Cole said he looked forward to working with the team to expand impact, strengthen partnerships, and continue delivering on the company’s mission.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: Vālenz Health leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


